Thursday, 30 May 2013

ISPOR 18th Annual International Meeting: BG12 and steroid usage

BG12 reduces the severity of relapses. #MSBlog #MSResearch

"My poster from the ISPOR 18th Annual International Meeting in New Orleans. The main finding is that BG12 or DMF reduces the proportion of relapses needing to be treated with intravenous steroids. Use of steroids is a surrogate for the severity of relapses; in other words BG12 not only reduces the number of relapse, but also the severity of relapses. This is good news as high-dose steroids are not without risks. As I have said before steroids can have severe side effects and should be avoided if possible."

No comments:

Post a Comment

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.